Ads
related to: lipitor pfizer astellas generic brandnexlizet.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Three U.S. senators are raising questions with Pfizer (NYS: PFE) over its deal making for its megablockbuster cholesterol drug Lipitor as generic drug makers step up to market the drug, most ...
Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market. The pharma distributors claimed Pfizer fraudulently sought to extend ...
In 1996, Warner-Lambert entered into a co-marketing agreement with Pfizer to sell Lipitor, and in 2000, Pfizer acquired Warner-Lambert for $90.2 billion. [116] [106] [112] [113] Lipitor was on the market by 1996. [114] [117] By 2003, Lipitor had become the best selling pharmaceutical in the United States. [110]
But this time it's Pfizer (NYS: PFE) and Merck (NYS: Usually, it's a branded drugmaker fighting off a generics challenge from a copycat drugmaker. Pfizer Sues Merck to Block Lipitor/Zetia Combo Pill
The best-selling statin is atorvastatin, also known as Lipitor, which in 2003 became the best-selling pharmaceutical in history. [12] The manufacturer Pfizer reported sales of US$12.4 billion in 2008. [13] Patient compliance with statin usage is problematic despite robust evidence of the benefits. [14] [15]
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]